SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001193125-20-253529
Filing Date
2020-09-24
Accepted
2020-09-24 17:28:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13E3/A d50276dsc13e3a.htm SC 13E3/A 29551
  Complete submission text file 0001193125-20-253529.txt   31136
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filed by) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Subject) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-90051 | Film No.: 201196142
SIC: 2834 Pharmaceutical Preparations